REQUEST A DEMO
Total
USD $0.00
Search more companies

Rodinny Lekar Mudr. Novakova S.R.O. (Czech Republic)

Main Activities: Real Estate
Full name: Rodinny Lekar Mudr. Novakova S.R.O. Profile Updated: November 09, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Rodinny Lekar Mudr. Novakova S.R.O. is based in Czech Republic, with the head office in Malenovice. It operates in the Real Estate industry. Rodinny Lekar Mudr. Novakova S.R.O. was incorporated on September 14, 2021. 10 - 19 (2024) employees currently work for Rodinny Lekar Mudr. Novakova S.R.O.. From the latest financial highlights, Rodinny Lekar Mudr. Novakova S.R.O. reported a net sales revenue increase of 8.16% in 2023. Its’ total assets recorded a growth of 10.37%. Rodinny Lekar Mudr. Novakova S.R.O.’s net profit margin increased by 5.29% in 2023.

Headquarters
Malenovice 280
Malenovice; Moravskoslezsky; Postal Code: 73911

Contact Details: Purchase the Rodinny Lekar Mudr. Novakova S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Rodinny Lekar Mudr. Novakova S.R.O. report to view the information.
Outstanding Shares:
Purchase the Rodinny Lekar Mudr. Novakova S.R.O. report to view the information.
Registered Capital:
Purchase the Rodinny Lekar Mudr. Novakova S.R.O. report to view the information.
Incorporation Date:
September 14, 2021
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Rodinny Lekar Mudr. Novakova S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
8.16%
Total operating revenue
10.88%
Operating profit (EBIT)
71.41%
EBITDA
74.25%
Net Profit (Loss) for the Period
70.33%
Total assets
10.37%
Total equity
173.05%
Operating Profit Margin (ROS)
6.59%
Net Profit Margin
5.29%
Return on Equity (ROE)
-38.18%
Quick Ratio
1.86%
Cash Ratio
1.53%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?